Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial

BACKGROUND: Tenofovir disoproxil fumarate (TDF) in combination with other antiretroviral (ARV) drugs has been in clinical use for HIV treatment since its approval in 2001. Although the effectiveness of TDF in preventing perinatal HIV infection is well established, information about renal safety duri...

Descripción completa

Detalles Bibliográficos
Autores principales: Baltrusaitis, Kristin, Makanani, Bonus, Tierney, Camlin, Fowler, Mary Glenn, Moodley, Dhayendre, Theron, Gerhard, Nyakudya, Lynette H., Tomu, Musunga, Fairlie, Lee, George, Kathleen, Heckman, Barbara, Knowles, Kevin, Browning, Renee, Siberry, George K., Taha, Taha E., Stranix-Chibanda, Lynda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297643/
https://www.ncbi.nlm.nih.gov/pubmed/35858874
http://dx.doi.org/10.1186/s12879-022-07608-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297643/
https://www.ncbi.nlm.nih.gov/pubmed/35858874
http://dx.doi.org/10.1186/s12879-022-07608-8

Ejemplares similares